Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators.; ROCKET AF Steering Committee Investigators..

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

2.

[Sinus pilonidalis - possibilities of surgical treatment].

Jandík J.

Rozhl Chir. 2014 Oct;93(10):496-501. Czech.

PMID:
25340864
3.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators..

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008.

4.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators..

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907.

5.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators..

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797.

6.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators..

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X.

PMID:
22402056
7.

[Acute appendicitis--overview of current knowledge].

Jandík J.

Rozhl Chir. 2011 Oct;90(10):568-74. Review. Czech.

PMID:
22324253
8.

Incidence, predisposing factors, and aetiology of infective endocarditis in the Czech Republic.

Dzupova O, Machala L, Baloun R, Maly M, Benes J; Czech Infective Endocarditis Working Group..

Scand J Infect Dis. 2012 Apr;44(4):250-5. doi: 10.3109/00365548.2011.632643.

PMID:
22122645
9.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators..

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277.

10.

[Acute appendicitis--early complications and significance of antibiotic prophylaxis].

Jandík J.

Rozhl Chir. 2011 Jul;90(7):408-13. Czech.

PMID:
22026093
11.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators..

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638.

12.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators..

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
13.

[A necrotizing fasciitis of an abdominal wall after a cholecystectomy--a case report].

Jandík J, Vokůrka J.

Rozhl Chir. 2009 Jan;88(1):27-31. Czech.

PMID:
19358467
14.

[Changes in late potentials in the time period after myocardial infarct].

Ceral J, Kvasnicka J, Jandík J.

Acta Medica (Hradec Kralove) Suppl. 1999;42(1):7-12. Czech.

PMID:
11253313
15.

Changes of signal-averaged ECG in normal subjects after one year.

Ceral J, Kvasnicka J, Jandík J.

Acta Medica (Hradec Kralove). 1999;42(1):15-7.

PMID:
10566175
16.

[The role of the atrium and optimal values of AV intervals in sequentially paced patients].

Kvasnicka J, Mĕst'an M, Tauchman M, Tusl Z, Rozsíval V, Jandík J, Gajdosová I.

Vnitr Lek. 1997 May;43(5):340-4. Czech.

PMID:
9601861
17.

Atrial contribution to ventricular ejection in sequentially paced patients.

Kvasnicka J, Tauchman M, Kovár D, Jandík J, Gajdosová I, Rejchrt P.

Physiol Res. 1996;45(2):159-63.

PMID:
9496766
18.

Bronchial arteries in experimental pulmonary infarction: angiographic and morphometric study.

Jandík J, Endrys J, Rehulová E, Mráz J, Sedlácek J, De Geest H.

Cardiovasc Res. 1993 Jun;27(6):1076-83.

PMID:
8221767
19.

[The role of the exercise test in patients with ischemic heart disease in estimating the risk of sudden death].

Barták K, Pidrman V, Kvasnicka J, Hlava A, Podrabský P, Vokrouhlický L, Cihulová L, Jandík J, Ettlerová E.

Vnitr Lek. 1991 May;37(5):449-56. Czech.

PMID:
1842142
20.

[Systolic and diastolic intervals in patients with hypertrophic obstructive cardiomyopathy before and after withdrawal of verapamil].

Jandík J, Kvasnicka J, Vokrouhlický L.

Bratisl Lek Listy. 1990 Sep;91(9):701-4. Czech.

PMID:
2224552
Items per page

Supplemental Content

Loading ...
Support Center